- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.12.25 | Bon Natural Life enters $12M sales agreement with Qingshengyuan | 1 | Seeking Alpha | ||
| 10.12.25 | Bon Natural Life Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 25.11.25 | Bon Natural Life signs $26 million distribution agreement for tea products | 4 | Investing.com | ||
| BON NATURAL LIFE Aktie jetzt für 0€ handeln | |||||
| 25.11.25 | Bon Natural Life Limited: BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan | 116 | PR Newswire | XI'AN, China, Nov. 25, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural... ► Artikel lesen | |
| 25.11.25 | Bon Natural Life Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 14.11.25 | Bon Natural Life Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 29.09.25 | Bon Natural Life Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 09.09.25 | Bon Natural Life signs $18 million distribution deal for apple products | 3 | Investing.com | ||
| 09.09.25 | Bon Natural Life schließt Vertriebsdeal über 18 Millionen US-Dollar für Apple-Produkte | 5 | Investing.com Deutsch | ||
| 09.09.25 | Bon Natural Life Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 05.08.25 | Bon Natural Life regains Nasdaq compliance | 1 | Seeking Alpha | ||
| 05.08.25 | Bon Natural Life Limited: BON Announces Reciept of Nasdaq Compliance Letter | 167 | PR Newswire | XI'AN, China, Aug. 5, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for... ► Artikel lesen | |
| 05.08.25 | Bon Natural Life Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 21.07.25 | Bon Natural Life stock rises on new $22 million distribution deal | 1 | Investing.com | ||
| 21.07.25 | 22-Millionen-Dollar-Deal beflügelt Aktie von Bon Natural Life | 1 | Investing.com Deutsch | ||
| 21.07.25 | Bon Natural Life signs $22 million distribution deal for weight loss line | 2 | Investing.com | ||
| 21.07.25 | Bon Natural Life Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 14.07.25 | Bon Natural Life regains compliance Nasdaq listing rule | 3 | Seeking Alpha | ||
| 14.07.25 | Bon Natural Life Limited: BON Announces Nasdaq Compliance | 149 | PR Newswire | XI'AN, China, July 14, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the... ► Artikel lesen | |
| 11.07.25 | Bon Natural Life Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,100 | 0,00 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,300 | +1,33 % | Where Alignment Healthcare Stands With Analysts | ||
| FRESENIUS MEDICAL CARE | 40,220 | 0,00 % | Abend-Update: Fresenius Medical Care sorgt für Spannung - kommt bald die Entscheidung? | ||
| FRESENIUS | 48,440 | 0,00 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,340 | 0,00 % | Abend-Update: Carl Zeiss Meditec-Aktie auf Höhenflug - Anleger feiern starkes Comeback! | ||
| GENEDX | 135,80 | +3,34 % | GeneDx Taps Dr. Linda Genen as Chief Medical Officer | ||
| BRIGHTSPRING HEALTH SERVICES | 40,670 | +3,59 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PACS GROUP | 40,880 | 0,00 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,720 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 26,670 | +0,09 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 4,130 | +5,09 % | Oncology Institute, Inc. - 8-K, Current Report | ||
| GERRESHEIMER | 27,900 | 0,00 % | Gerresheimer Aktie: Einer der Rebound-Favoriten für 2026! | © Foto: Foto von Tima Miroshnichenko auf PexelsNach einem verheerenden Börsenjahr 2025 könnte die Gerresheimer-Aktie jetzt die große Überraschung werden.Der Pharmaverpackungs-Spezialist aus Düsseldorf... ► Artikel lesen | |
| BILLIONTOONE | 94,93 | -0,39 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| RXSIGHT | 9,990 | -4,58 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| CERIBELL | 21,730 | 0,00 % | CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection |
Das Unternehmen BON NATURAL LIFE LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,670 Euro und damit -1,76 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BON NATURAL LIFE LIMITED finden Sie auf Wallstreet Online.